Biocryst stock news
WebAug 2, 2024 · RESEARCH TRIANGLE PARK, N.C., Aug. 02, 2024 (GLOBE NEWSWIRE) -- BioCryst Pharmaceuticals, Inc. (NASDAQ:BCRX) announced today the dosing of the first subject into ZENITH-1, a clinical trial ... WebApr 6, 2024 · SA News Fri, Mar. 18, 2024 3 Comments BioCryst executive sells 20K company shares in first insider selling since May 2024 SA News Thu, Mar. 10, 2024 12 Comments
Biocryst stock news
Did you know?
WebMar 24, 2024 · BioCryst Pharmaceuticals Inc Stock Price History. BioCryst Pharmaceuticals Inc’s price is currently down 3.95% so far this month. During the month of March, BioCryst Pharmaceuticals Inc’s stock price has reached a high of $8.99 and a low of $7.82. ... Lastly, news and media coverage as well as recent press reports about the … WebApr 12, 2024 · April 12, 2024 - 7:00 am. RESEARCH TRIANGLE PARK, N.C., April 12, 2024 (GLOBE NEWSWIRE) -- BioCryst Pharmaceuticals, Inc. (Nasdaq: BCRX) today announced that the company will present at the following investor conferences: The 22 nd Annual Needham Virtual Healthcare Conference on Wednesday, April 19 th at 8:45 a.m. ET; The …
WebThe 50-day moving average is a frequently used data point by active investors and traders to understand the trend of a stock. It’s calculated by averaging the closing stock price … WebApr 6, 2024 · A high-level overview of BioCryst Pharmaceuticals, Inc. (BCRX) stock. Stay up to date on the latest stock price, chart, news, analysis, fundamentals, trading and …
WebApr 12, 2024 · April 12, 2024 - 7:00 am. RESEARCH TRIANGLE PARK, N.C., April 12, 2024 (GLOBE NEWSWIRE) -- BioCryst Pharmaceuticals, Inc. (Nasdaq: BCRX) today … WebBioCryst Pharmaceuticals, Inc. is an American pharmaceutical company headquartered in Durham, North Carolina. The company is a late stage biotech company that focuses on oral drugs for rare and serious diseases. ... BioCryst became a public company when it completed an initial public offering by listing its shares on the NASDAQ stock exchange ...
WebApr 6, 2024 · Financial Performance. In 2024, BCRX's revenue was $270.83 million, an increase of 72.31% compared to the previous year's $157.17 million. Losses were -$247.12 million, 34.3% more than in 2024. Financial Statements.
WebApr 12, 2024 · April 12, 2024, 4:00 AM · 1 min read. BioCryst Pharmaceuticals, Inc. RESEARCH TRIANGLE PARK, N.C., April 12, 2024 (GLOBE NEWSWIRE) -- BioCryst Pharmaceuticals, Inc. (Nasdaq: BCRX) today announced ... ironspire complex adamstown paWebApr 4, 2024 · RESEARCH TRIANGLE PARK, N.C., April 04, 2024 (GLOBE NEWSWIRE) -- BioCryst Pharmaceuticals, Inc. (Nasdaq: BCRX) today announced that the compensation committee of BioCryst’s board of directors granted six newly-hired employees stock options to purchase an aggregate of 124,300 shares, and restricted stock units (RSUs) … port wine dessert recipeWebJul 16, 2024 · Biocryst Pharmaceuticals (NASDAQ: BCRX) is an American pharmaceutical company. With year-to-date share gains of 114%, the late-stage biotech company, focused on the development of oral drugs for ... ironstaff of regenerationWebNews. Congrats, shorts & condolences, longs! Looks like BioCryst is reporting, in a very protective way, that they are seeing some sort of toxicity signal with 10013, in preclinical, animal tox data. This was their backup Factor D inhibitor that was going to be the next great thing, after 9930 was shelved. There goes the entire pipeline for the ... port wine diseaseWebMay 4, 2024 · On May 5, BioCryst Pharmaceuticals will report earnings from the Q1. 12 analysts predict losses of $0.363 per share compared to losses of $0.360 per share in the same quarter of the previous year ... ironstache adWebApr 14, 2024 · In other BioCryst Pharmaceuticals news, CEO Jon P. Stonehouse sold 100,000 shares of the company's stock in a transaction that occurred on Wednesday, … ironstate apartmentsWebApr 8, 2024 · RBC Capital analyst Brian Abrahams maintained a Hold rating on BioCryst ( BCRX – Research Report) on April 6 and set a price target of $9.00. The company’s … ironstate